Prevalence of hypermutator isolates of Achromobacter spp. from cystic fibrosis patients.

Int J Med Microbiol

Department of Clinical Microbiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.

Published: February 2020

Bacteria colonising the lungs of cystic fibrosis (CF) patients encounter high selective pressures. Hypermutation facilitates adaptation to fluctuating environments, and hypermutator strains are frequently isolated from CF patients. We investigated the prevalence of hypermutator isolates of Achromobacter spp. among patients affiliated with the CF Centre in Aarhus, Denmark. By exposure to rifampicin, the mutation frequency was determined for 90 isolates of Achromobacter spp. cultured from 42 CF patients; 20 infections were categorised as chronic, 22 as intermittent. The genetic mechanisms of hypermutation were examined by comparing DNA repair gene sequences from hypermutator and normomutator isolates. Achromobacter spp. cultured from 11 patients were categorised as hypermutators, and this phenotype was exclusively associated with chronic infections. Isolates of the Danish epidemic strain (DES) of Achromobacter ruhlandii cultured from patients from both Danish CF centres showed elevated mutation frequencies. The hypermutator state of Achromobacter spp. was most commonly associated with nonsynonymous mutations in the DNA mismatch repair gene mutS; a single clone had developed a substitution in the S-adenosyl-L-methionine-dependent methyltransferase putatively involved in DNA repair mechanisms, but not previously linked to the hypermutator phenotype. Hypermutation is prevalent among clinical isolates of Achromobacter spp. and could be a key determinant for the extraordinary adaptation and persistence of DES.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijmm.2020.151393DOI Listing

Publication Analysis

Top Keywords

achromobacter spp
24
isolates achromobacter
20
cultured patients
12
prevalence hypermutator
8
hypermutator isolates
8
cystic fibrosis
8
fibrosis patients
8
spp cultured
8
dna repair
8
repair gene
8

Similar Publications

Purpose: Achromobacter spp. may form biofilm in patients' respiratory tracts and cause serious infections. This research examined the bactericidal and synergistic effects of ceftazidime/avibactam (CZA) alone and in combination with different antibiotics against Achromobacter spp.

View Article and Find Full Text PDF
Article Synopsis
  • Thawing permafrost releases pathogens and antibiotic-resistant genes (ARGs), which can lead to bacterial epidemics in circumpolar regions.
  • Researchers studied the link between climate change, permafrost thawing, and the potential global healthcare impacts of these antibiotic-resistant pathogens.
  • Their analysis of 13 studies identified diverse bacterial genera with over 1,000 ARGs, highlighting the need for increased awareness and action regarding this emerging healthcare challenge.
View Article and Find Full Text PDF
Article Synopsis
  • Arsenic contamination is a significant public health issue globally, and bacteria like Achromobacter aegrifaciens can help mitigate this by converting toxic arsenite (AsIII) into less harmful arsenate (AsV).
  • Researchers analyzed two A. aegrifaciens strains from arsenic-laden water and soil in Bangladesh using whole genome sequencing and found that both strains exhibit arsenic oxidation capabilities and share similar gene clusters for arsenic detoxification and heavy metal resistance.
  • The genomic analyses revealed that these strains, while distinct from other strains globally, show close evolutionary relationships with each other, indicating their potential in bioremediation efforts in arsenic-contaminated areas.
View Article and Find Full Text PDF

Genomic characterization of Achromobacter genogroup 20 and identification of a potential species-specific marker.

J Glob Antimicrob Resist

November 2024

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Laboratorio de Resistencia Bacteriana, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Article Synopsis
  • The study aimed to analyze the genome of Achromobacter genogroup 20 and identify resistance determinants related to antibiotic resistance.
  • Isolate 413638 was classified as Achromobacter genogroup 20 ST365, demonstrating significant resistance to multiple antibiotics and possessing several resistance-related genetic elements, including a newly identified OXA-type β-lactamase.
  • The findings suggest that the resistance markers identified could explain the antibiotic resistance profile of Achromobacter genogroup 20 ST365, with the new OXA variant potentially serving as a useful marker for further species identification.
View Article and Find Full Text PDF

The triple combination elexacaftor-tezacaftor-ivacaftor (ETI) has provided unprecedented clinical benefits for people with cystic fibrosis (pwCF) and drastically transformed the outcome of this disease. We aimed to describe the evolution of lung bacterial colonization in 198 French adult pwCF taking into account the use of concomitantly respiratory treatment. We collected sputum cultures produced during the entire follow-up period starting 3 years before and ending 1 year after ETI initiation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!